Gong D, Yang R, Munir KM, Horenstein RB, Shuldiner AR: New progress in adipocytokine research. Current Opinion in Endocrinology & Diabetes 2003, 10: 115-121. 10.1097/00060793-200304000-00004
Kalant D, Maslowska M, Scantlebury T, Wang H, Cianflone K: Control of lipogenesis in adipose tissue and the role of Acylation Stimulating Protein. Canadian Journal of Diabetes 2003, 27: 154-171.
Jazet IM, Pijl H, Meinders AE: Adipose tissue as an endocrine organ: impact on insulin resistance. The Netherlands Journal of Medicine 2003, 61: 194-212.
Havel PJ: Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Current Opinion in Lipidology 2002, 13: 51-59. 10.1097/00041433-200202000-00008
Cianflone K, Sniderman AD, Walsh MJ, Vu H, Gagnon J, Rodriguez MA: Purification and characterization of acylation stimulating protein. Journal of Biological Chemistry 1989, 264: 426-430.
Poledne R, Pisa Z, Berg K: Normal genetic variation at the low density lipoprotein receptor (LDLR) locus influences cholesterol levels in children. Clinical Genetics 1993, 43: 122-126.
Baldo A, Sniderman AD, St-Luce S, Avramoglu RK, Maslowska M, Hoang B, Monge JC, Bell A, Mulay S, Cianflone K: The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. Journal of Clinical Investigation 1993, 92: 1543-1547.
Yasruel Z, Cianflone K, Sniderman AD, Rosenbloom M, Walsh M, Rodriguez MA: Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991, 26: 495-499. 10.1007/BF02536592
Kalant D, Maclaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K: C5L2 is a functional receptor for acylation stimulating protein. Journal of Biological Chemistry 2005, 280: 23936-44. 10.1074/jbc.M406921200
Cianflone K, Roncari DAK, Maslowska M, Baldo A, Forden J, Sniderman AD: The adipsin/acylation stimulating protein system in human adipocytes: Regulation of triacylglycerol synthesis. Biochemistry 1994, 33: 9489-9495. 10.1021/bi00198a014
Cianflone K, Maslowska M, Sniderman AD: Acylation stimulating protein (ASP), an adipocyte autocrine: new directions. Seminars in Cell & Developmental Biology 1999, 10: 31-41. 10.1006/scdb.1998.0272
Maslowska M, Wang HW, Cianflone K: Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitamins and Hormones 2005, 70: 309-332. 10.1016/S0083-6729(05)70010-8
Maslowska M, Legakis H, Assadi F, Cianflone K: Targeting the signaling pathway of acylation stimulating protein. Journal of Lipid Research 2006, 47: 643-52. 10.1194/jlr.M500500-JLR200
Cianflone K, Zakarian R, Couillard C, Delplanque B, Despres JP, Sniderman AD: Fasting acylation stimulating protein is predictive of postprandial triglyceride clearance. Journal of Lipid Research 2004, 45: 124-131. 10.1194/jlr.M300214-JLR200
Murray I, Sniderman AD, Cianflone K: Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57Bl/6 mice. American Journal of Physiology: Endocrinology and Metabolism 1999, 277: E474-E480.
Saleh J, Christou N, Cianflone K: Regional specificity of ASP binding in human adipose tissue. American Journal of Physiology 1999, 276: E815-E821.
Murray I, Sniderman AD, Cianflone K: Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. Journal of Lipid Research 1999, 40: 1671-1676.
Murray I, Sniderman AD, Havel PJ, Cianflone K: Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. Journal of Biological Chemistry 1999, 274: 36219-36225. 10.1074/jbc.274.51.36219
Xia Z, Stanhope KL, Digitale E, Simion O-M, Chen LY, Havel PJ, Cianflone K: ASP deficiency results in increased energy expenditure in mice. Journal of Biological Chemistry 2004, 279: 4051-4057. 10.1074/jbc.M311319200
Saleh J, Sniderman AD, Cianflone K: Postprandial triacylglycerol clearance in ob/ob and db/db mice: physiological effects of ASP in mouse models of obesity and hypertriglyceridemia. International Journal of Obesity and Related Metabolic Disorders 1998, 22: S183.
Murray I, Havel PJ, Sniderman AD, Cianflone K: Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000, 141: 1041-1049. 10.1210/en.141.3.1041
Xia Z, Sniderman AD, Cianflone K: Acylation-stimulating Protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. Journal of Biological Chemistry 2002, 277: 45874-45879. 10.1074/jbc.M207281200
Saleh J, Summers LKM, Cianflone K, Fielding BA, Sniderman AD, Frayn KN: Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. Journal of Lipid Research 1998, 39: 884-891.
Kalant D, Phelis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD: Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. Journal of Lipid Research 2000, 41: 1963-1968.
Maslowska M, Scantlebury T, Germinario R, Cianflone K: Acute in vitro production of ASP in differentiated adipocytes. Journal of Lipid Research 1997, 38: 21-31.
Scantlebury T, Maslowska M, Cianflone K: Chylomicron specific enhancement of Acylation Stimulating Protein (ASP) and precursor protein C3 production in differentiated human adipocytes. Journal of Biological Chemistry 1998, 273: 20903-20909. 10.1074/jbc.273.33.20903
Scantlebury T, Sniderman AD, Cianflone K: Retinoic acid regulation of Acylation Stimulating Protein (ASP) and complement C3 in human adipocytes. Biochemistry Journal 2001, 356: 445-452. 10.1042/0264-6021:3560445
Cianflone K, Xia Z, Chen LY: Critical review of Acylation Stimulating Protein physiology in humans and rodents. Biochimica et Biophysica Acta 2003, 1609: 127-143. 10.1016/S0005-2736(02)00686-7
Cianflone K, Lu H, Smith J, Yu W, Wang H: Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clinical Endocrinology 2005, 62: 567-72. 10.1111/j.1365-2265.2005.02260.x
Yang Y, Lu HL, Zhang J, Yu HY, Wang HW, Zhang MX, Cianflone K: Relationships among acylation stimulating protein, adiponectin and complement C3 in lean vs obese type 2 diabetes. International Journal of Obesity 2006, 30: 439-46. 10.1038/sj.ijo.0803173
Peake PW, Kriketos AD, Campbell LV, Charlesworth JA: Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. International Journal of Obesity 2005, 29: 429-35. 10.1038/sj.ijo.0802644
Engstrom G, Hedblad B, Eriksson KF, Janzon L, Lindgarde F: Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. Diabetes 2005, 54: 570-5. 10.2337/diabetes.54.2.570
Tan GD, Fielding BA, Currie JM, Humphreys SM, Desage M, Frayn KN, Laville M: The effects of rosiglitazone on fatty acid and triglyceride metabolism in type 2 diabetes. Diabetologia 2005, 48: 83-95. 10.1007/s00125-004-1619-9
Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN: Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 2002, 51: 2684-2690. 10.2337/diabetes.51.9.2684
Maslowska M, Vu H, Phelis S, Sniderman AD, Rhode BM, Blank D, Cianflone K: Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. European Journal of Clinical Investigation 1999, 29: 679-686. 10.1046/j.1365-2362.1999.00514.x
Havel PJ: Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 2004,53(Suppl 1):S143-S151. 10.2337/diabetes.53.2007.S143
Ahren B, Havel PJ, Pacini G, Cianflone K: Acylation stimulating protein stimulates insulin secretion. International Journal of Obesity and Related Metabolic Disorders 2003, 27: 1037-1043. 10.1038/sj.ijo.0802369
Stumvoll M, Haring HU: Glitazones: clinical effects and molecular mechanisms. Annals of Medicine 2002, 34: 217-24.
MacLaren R, Kalant D, Cianflone K: C5L2, the ASP receptor, is regulated by metabolic hormones associated with insulin resistance. Biochemistry & Cell Biology 2006.